A Structured Methodology that Guides Every Project from Initial Discovery to Successful Implementation.
Bringing a medical device from concept to market requires more than strong engineering, it requires a structured development process that ensures safety, regulatory compliance, and manufacturing readiness. Without a clear framework, projects can quickly encounter delays, redesigns, or regulatory obstacles.
At Pathway, we use a five-phase development approach that guides products from early concept through commercialization. Each phase builds on the previous one, helping teams manage risk, maintain traceability, and ensure the final device meets both user needs and regulatory expectations.
Pre-Design: Evaluating the Opportunity
Before formal design controls begin, new product ideas are evaluated to determine whether they are technically and commercially feasible.
During this early stage, teams may perform activities such as:
- Evaluating new product concepts
- Conducting business and feasibility analyses
- Developing preliminary drawings
- Prototyping early design concepts
This exploratory work allows teams to identify potential risks and refine the concept before significant development resources are committed.
Phase 1: Planning
The planning phase establishes the foundation for the entire project. During this stage, the development team defines the product concept and outlines the strategy that will guide the project.
Key elements defined during planning include:
- Product description and configuration
- Intended use of the device
- Project goals and development schedule
- Internal development team and project leadership
- External partners such as suppliers or consultants
- Regulatory strategy and applicable standards
- Risk management planning
At the end of this phase, a design review confirms that the development plans are clearly defined and the project is ready to proceed.
Phase 2: Design Inputs
Once the project is planned, the next step is translating the concept into clear design requirements.
Design inputs describe what the product must do and what constraints it must meet. These requirements incorporate information from multiple sources, including regulatory guidance, engineering considerations, and user needs.
Examples of design inputs may include:
- Regulatory and standards requirements
- Marketing and user needs
- Risk management considerations
- Engineering performance requirements
- Usability and safety considerations
- Manufacturing and sterilization constraints
- Packaging and labeling requirements
Establishing clear and complete requirements early in development helps prevent ambiguity and reduces the risk of costly design changes later in the process.
Phase 3: Design Outputs
In Phase 3, the development team converts design requirements into detailed product specifications.
These outputs define how the device will be manufactured and inspected, forming the foundation of the Device Master Record (DMR).
Typical design outputs include:
- Material specifications
- Assembly specifications
- Preliminary bill of materials (BOM)
- Software code and architecture documentation
At the end of this phase, the design is finalized and “frozen,” ensuring that the configuration used for testing represents the intended final product.
Phase 4: Design Verification and Validation
After the design is finalized, the product must be tested to confirm that it meets all requirements and performs as intended.
Two types of testing are conducted:
Design Verification – Confirms the design outputs meet the design inputs.
Design Validation – Confirms the device fulfills its intended use and meets user needs under real or simulated conditions.
Activities in this phase may include:
- First article inspection
- Packaging and labeling evaluations
- Product performance testing
- Biocompatibility assessments
- Sterilization validation
- Software verification and validation
- Usability evaluations
If issues are identified during testing, the design may be refined and re-evaluated before moving forward. Risk management documentation is also finalized during this phase.
Phase 5: Transfer to Manufacturing
The final phase prepares the device for commercial production.
Key activities include:
- Obtaining regulatory clearance or market authorization
- Finalizing the Device Master Record (DMR)
- Validating manufacturing and inspection processes
- Qualifying suppliers and manufacturing equipment
- Establishing post-market surveillance processes
Once these activities are complete, the product can move into full-scale manufacturing and distribution.
From Concept to Commercialization
Medical device development involves collaboration across engineering, regulatory, quality, and manufacturing teams. A structured development process helps ensure that each stage of the project is completed efficiently while maintaining compliance with industry regulations.
By following a clear five-phase approach, organizations can move from concept to commercialization with confidence while delivering safe and effective medical technologies to the market.